Evidence map›Paper›PMID 37018496›Full record

ArticleThe New England journal of medicine2023

An Alternate Explanation.

Tom Alsaigh, Gurpreet Dhaliwal, Eri Fukaya, Nicholas J Leeper, Nazish Sayed

Erratum issuedAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The New England journal of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. An Alternate Explanation.The New England journal of medicine · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Tom AlsaighFrom the Division of General Internal Medicine, Department of Medicine, and the Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, San Diego, La Jolla (T.A.), the Department of Medicine, University of California San Francisco School of Medicine, and Medical Service, San Francisco VA Medical Center, San Francisco (G.D.), and the Division of Vascular Surgery, Department of Surgery (E.F., N.J.L., N.S.), and the Division of Cardiovascular Medicine, Department of Medicine (N.J.L.), Stanford University School of Medicine, and the Stanford Cardiovascular Institute, Stanford University (N.J.L., N.S.), Stanford - all in California.
Gurpreet DhaliwalFrom the Division of General Internal Medicine, Department of Medicine, and the Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, San Diego, La Jolla (T.A.), the Department of Medicine, University of California San Francisco School of Medicine, and Medical Service, San Francisco VA Medical Center, San Francisco (G.D.), and the Division of Vascular Surgery, Department of Surgery (E.F., N.J.L., N.S.), and the Division of Cardiovascular Medicine, Department of Medicine (N.J.L.), Stanford University School of Medicine, and the Stanford Cardiovascular Institute, Stanford University (N.J.L., N.S.), Stanford - all in California.
Eri FukayaFrom the Division of General Internal Medicine, Department of Medicine, and the Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, San Diego, La Jolla (T.A.), the Department of Medicine, University of California San Francisco School of Medicine, and Medical Service, San Francisco VA Medical Center, San Francisco (G.D.), and the Division of Vascular Surgery, Department of Surgery (E.F., N.J.L., N.S.), and the Division of Cardiovascular Medicine, Department of Medicine (N.J.L.), Stanford University School of Medicine, and the Stanford Cardiovascular Institute, Stanford University (N.J.L., N.S.), Stanford - all in California.
Nicholas J LeeperFrom the Division of General Internal Medicine, Department of Medicine, and the Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, San Diego, La Jolla (T.A.), the Department of Medicine, University of California San Francisco School of Medicine, and Medical Service, San Francisco VA Medical Center, San Francisco (G.D.), and the Division of Vascular Surgery, Department of Surgery (E.F., N.J.L., N.S.), and the Division of Cardiovascular Medicine, Department of Medicine (N.J.L.), Stanford University School of Medicine, and the Stanford Cardiovascular Institute, Stanford University (N.J.L., N.S.), Stanford - all in California.
Nazish SayedFrom the Division of General Internal Medicine, Department of Medicine, and the Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, San Diego, La Jolla (T.A.), the Department of Medicine, University of California San Francisco School of Medicine, and Medical Service, San Francisco VA Medical Center, San Francisco (G.D.), and the Division of Vascular Surgery, Department of Surgery (E.F., N.J.L., N.S.), and the Division of Cardiovascular Medicine, Department of Medicine (N.J.L.), Stanford University School of Medicine, and the Stanford Cardiovascular Institute, Stanford University (N.J.L., N.S.), Stanford - all in California.

Funding

Deciphering the Endothelial Cell-Cardiomyocyte Crosstalk in LMNA CardiomyopathyR01HL158641 · NHLBI · STANFORD UNIVERSITY · PI SAYED, NAZISH · 2021 to 2025
$2.2M
Unraveling the role of endothelium in chemotherapy-induced cardiotoxicityR01HL161002 · NHLBI · STANFORD UNIVERSITY · PI SAYED, NAZISH · 2022 to 2025
$1.6M
NHLBI NIH HHS R01 HL158641NHLBI NIH HHS R01 HL161002
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37018496
PMCPMC10409491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.